Test Price
2,800 AED✅ Home Collection Available
TGFBI Gene Corneal Dystrophy Genetic Testing (NGS) in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited NGS Processing – definitive TGFBI variant detection for epithelial basement membrane corneal dystrophy.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport; VIP Mobile Phlebotomy by DHA‑licensed professionals.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance – board‑certified genetic counsellors interpret your results and clarify next steps.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – instant pre‑approval for major UAE networks.
- Specialist Oversight: Supervised by Consultant Medical Genetics, DHA Registration ID: 9294403 – ensuring clinical accuracy and ethical compliance.
Test Overview & Methodology
TGFBI Gene Corneal Dystrophy (Epithelial Basement Membrane) Genetic Test is a definitive molecular diagnostic that analyses the entire coding region of the TGFBI gene using Next Generation Sequencing, identifying pathogenic variants linked to epithelial basement membrane corneal dystrophy. This comprehensive genetic analysis enables precise diagnosis of hereditary corneal conditions and guides informed genetic counselling and management planning.
| Feature | Our Test – DNA Labs UAE | Closest Alternative |
|---|---|---|
| Precision | NGS full gene sequencing – >99.9% analytical sensitivity | Targeted mutation panel – limited variants, lower clinical yield |
| Methodology | ISO 9001:2015 certified NGS | Sanger sequencing / no certification |
| Speed | Report within 3–4 weeks (guaranteed) | Often 6–8 weeks, variable |
Physician Insight & Safety Protocols
“Every TGFBI genetic test I authorise represents a critical step toward diagnostic clarity for families affected by corneal dystrophy. A positive result can confirm hereditary epithelial basement membrane dystrophy, but I consistently emphasise that clinical correlation—including slit-lamp examination and documented family pedigree—remains indispensable. This test empowers families with precise molecular knowledge, yet it must be integrated with the complete ophthalmological and genetic counselling framework to guide prognosis and management.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA 9294403
Critical Medication Advisory
Do not discontinue any prescribed ocular therapy, including topical corticosteroids or immunomodulators, without direct consultation with your treating ophthalmologist. Abrupt cessation may precipitate acute corneal decompensation or inflammatory rebound. Always discuss your medication regimen with the genetic counselling team prior to sample collection.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active systemic infection, severe thrombocytopenia (platelets < 50×10⁹/L), inability to provide informed consent, contraindication to venipuncture (e.g., bilateral upper-limb lymphoedema).
- Pre-Test Requirement: Mandatory genetic counselling session to construct a pedigree chart and document affected family members – this ensures accurate interpretation of sequence variants.
- When to Seek Emergency Care: Sudden vision loss, intense eye pain, photophobia with corneal clouding, or suspected corneal perforation – visit your nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What does the TGFBI gene test detect, and why is it offered in the UAE?
This NGS test identifies pathogenic variants in the TGFBI gene that cause epithelial basement membrane corneal dystrophy with greater than 99.9% analytical sensitivity. In the UAE, the test is indicated when ophthalmologists suspect hereditary corneal dystrophy based on slit-lamp findings and family history. The result confirms the diagnosis, clarifies inheritance pattern, and guides genetic counselling and long-term surveillance planning.
2. How is the sample collected and what preparation is required?
A DHA-licensed phlebotomist visits your home for a painless venous blood draw or FTA card collection, with no fasting or dietary restrictions required. You may choose standard whole blood, an FTA card (one drop of blood), or submit previously extracted DNA if available. A mandatory pre-test genetic counselling session will document a detailed pedigree. Inform the team of any anticoagulant use, but no drug withholding is necessary.
3. Will insurance cover this genetic test and how quickly will I get results?
Most UAE insurers cover medically indicated TGFBI genetic testing; contact us via WhatsApp at +971545488731 for instant eligibility verification. Once the sample reaches our ISO-certified laboratory, the NGS analysis and clinical interpretation are completed within 3 to 4 weeks. Our billing team handles direct submissions, and any out-of-pocket costs are communicated upfront before processing begins.
4. What are the limitations and what happens after a positive result?
A positive result confirms a pathogenic TGFBI variant but does not predict disease severity or progression rate. Clinical correlation with ophthalmological examination and family history remains essential. After a positive result, you will receive a detailed post-test genetic counselling session to discuss inheritance risks, implications for relatives, and screening recommendations. No therapeutic decisions should be made solely on genetic findings without specialist consultation.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Compliance Framework
Your genetic data is processed exclusively in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE maintains ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) for its laboratory quality management system.
Your genetic information is encrypted, access-restricted, and never shared with third parties without your explicit written consent. All data handling complies with UAE healthcare data sovereignty requirements and international best practices for genomic privacy.
Clinical & Logistical Metadata
| Test Name | TGFBI Gene Corneal Dystrophy (Epithelial Basement Membrane) Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (venous) or FTA card (dried blood spot) or previously extracted DNA |
| Methodology Used | Next Generation Sequencing (NGS) – full coding region analysis |
| ICD-10-CM Code | H18.53 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians